Abbvie Inc

-0.18 (-0.15%)
4:00:00 PM EDT: $116.39 -0.03 (-0.03%)
Products, Strategic Combinations

HBM Holdings Updates On Collaboration With Abbvie, Utrecht University For Co-Development Of HBM9022

Published: 12/09/2020 01:49 GMT
Abbvie Inc (ABBV) - On Dec 3, Abbvie Inc, Unit, Utrecht University Holding Bv and Universiteit Utrecht Entered License Agreement.
Agreement for Advancement of Development of Covid-19 Neutralizing Antibody 47d11.
Under Agreement, Abbvie to Conduct Clinical Development of Antibody, & If Successful, Will Manufacture & Commercialize Product Worldwide.